Soliris works by selectively inhibiting activation of specific proteins in the complement system (C5a and C5b), which play a role in the pathophysiology of multiple rare diseases.
Vyvgart (efgartigimod alfa-fcab) is a prescription medication used for the treatment of generalized myasthenia gravis in adults who are positive for antibodies directed toward a protein called the acetylcholine receptor (anti-AChR antibody positive).
Ultomiris is a medication used for the treatment of generalized myasthenia gravis
(gMG) in adult patients who are anti-acetylcholine receptor (AchR) antibody positive as
well as those with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic
uremic syndrome (aHUS).